Contrast enhanced ultrasound of breast cancer.
The importance of ultrasound examination in the diagnosis of breast cancer has been widely demonstrated. During the last few years, the introduction of ultrasound contrast media has been considered a promising tool for studying the vascular pattern of focal lesions within the breast. Our purpose was to assess whether contrast-enhanced (CE) ultrasound examination, performed using specific contrast imaging modes, can be helpful for detection and characterization of breast lesions, and for prediction of the response of breast cancer to therapy.
Breast Imaging Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. enrico.cassano@ieo.it
E
E
Cassano
S
S
Rizzo
A
A
Bozzini
S
S
Menna
M
M
Bellomi
D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D007089:Image Enhancement; D008833:Microcirculation; D008875:Middle Aged; D010743:Phospholipids; D010865:Pilot Projects; D018719:Erb-b2 Receptor Tyrosine Kinases; D013459:Sulfur Hexafluoride; D000068878:Trastuzumab; D018608:Ultrasonography, Doppler; D016217:Ultrasonography, Mammary
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D010743:Phospholipids; D018719:Erb-b2 Receptor Tyrosine Kinases; D013459:Sulfur Hexafluoride; D000068878:Trastuzumab; C420843:contrast agent BR1